Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
The Consortium for Clinical Research and Innovation (CRIS) will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 to check if you are unsure if something is a scam or visit the ScamShield (opens in new tab) website for more information.

Consortium for Clinical Research and Innovation, Singapore (CRIS)
Media Releases

Media Coverage: NHIC to accelerate local healthtech innovations in Singapore with up to S$1M grant

19 October 2022

The National Health Innovation Centre, Singapore (NHIC) has launched a Clinical Innovation and Adoption Initiative to nurture promising healthtech projects for adoption and scaling across healthcare clusters in Singapore.

This article has been migrated from an earlier version of the site and may display formatting inconsistencies.

Five people in business attire stand in front of a wall displaying the launch of the Clinical Innovation and Adoption Initiative.

The National Health Innovation Centre, Singapore (opens in new tab) (NHIC) has launched a Clinical Innovation and Adoption Initiative to nurture promising healthtech projects for adoption and scaling across healthcare clusters in Singapore.

Projects selected can expect to receive funding of up to S$1 million each. The initiative is supported by the Ministry of Health and covers three clinical adoption themes: Screening, Diagnostics and Monitoring, and Intervention. The grant call (opens in new tab) for the first theme will open in November 2022.

The Clinical Innovation and Adoption Initiative is part of the expansion of NHIC’s programmes to offer a holistic suite of support to power the development and adoption of healthtech innovations in Singapore, and facilitate their eventual commercialisation and scaling in and beyond Singapore, so as to ensure the cost-effectiveness of these innovations through economies of scale.

Read more about the announcements via the media coverage below: